Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | CASP6 | P55212 | 1/20 | 0.30 |
| ▸ | GFER | P55789 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4439029 | 0.75 | NR1H2 (0.42) | — | |
| SCHEMBL11177509 | 0.71 | — | — | |
| SCHEMBL16795955 | 0.67 | MEN1 (0.35) | NOTUM | |
| SCHEMBL5969104 | 0.65 | NOTUM (0.32) | NOTUM | |
| SCHEMBL27390204 | 0.63 | — | — | |
| SCHEMBL4788208 | 0.61 | — | — | |
| SCHEMBL6168375 | 0.60 | HSD17B3 (0.49) | NOTUM | |
| SCHEMBL30532798 | 0.60 | CYP3A4 (0.31) | — | |
| SCHEMBL2492988 | 0.59 | NOTUM (0.31) | NOTUM | |
| SCHEMBL11490070 | 0.58 | TSHR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130172562-A1 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | DR. REDDY'S LABORATORIES, INC. (US) | 2013-07-04 | — | — | US | claimed |
| EP-2582671-A2 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | Dr. Reddy's Laboratories Ltd. (IN) | 2013-04-24 | — | — | EP | claimed |
| WO-2011160037-A2 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-12-22 | — | — | WO | claimed |
| US-20130172562-A1 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | DR. REDDY'S LABORATORIES, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| US-20130172562-A1 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | DR. REDDY'S LABORATORIES, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| EP-2582671-A2 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | Dr. Reddy's Laboratories Ltd. (IN) | 2013-04-24 | — | — | EP | disclosed |
| EP-2582671-A2 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | Dr. Reddy's Laboratories Ltd. (IN) | 2013-04-24 | — | — | EP | disclosed |
| WO-2011160037-A3 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | DR. REDDY'S LABORATORIES LTD. (IN) | 2012-04-05 | — | — | WO | disclosed |
| WO-2011160037-A2 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-12-22 | — | — | WO | disclosed |
| WO-2011160037-A2 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172562-A1 | PROCESS FOR THE PREPARATION OF A SINGLE ENANTIOMER OF 3-AMINOPIPERIDINE DIHYDROCHLORIDE | RAC3, RAC2, RAPGEF4 | NOTUM 3034/4885CASP6 4079/4885GFER 3265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.